Percutaneous mechanical atherothrombectomy using the RotarexS device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients.

Date publication

janvier 2020

Journal

Quantitative imaging in medicine and surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LOFFROY Romaric

Tous les auteurs :
Loffroy R, Edriss N, Goyault G, Chabanier A, Pernes JM, Sauguet A, Touil M, Woerly B, Pongas D, Chevallier O, Falvo N, Galland C, Midulla M, Garnier N, Guenfoudi MP, Boulin M, Aho-Gléglé S, Bost S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31956549

Résumé

To ascertain the safety and mid-term outcomes of RotarexS rotational atherectomy plus thrombectomy device (Straub Medical AG, Wangs, Switzerland) with or without adjunctive treatment (e.g., percutaneous transluminal angioplasty, PTA/drug-coated balloon, DCB/stenting) in patients with in-stent restenosis (ISR) or occlusion in the iliac and/or infrainguinal arteries.

Mots clés

Lower limb ischemia, drug-coated balloon (DCB), in-stent occlusion, in-stent restenosis (ISR), rotational atherectomy angioplasty

Référence

Quant Imaging Med Surg. 2020 Jan;10(1):283-293